Business
Promising antibody response in Australians given Novavax COVID-19 vaccine – Sydney Morning Herald
An early-stage trial of a promising COVID-19 vaccine found high levels of coronavirus-neutralising antibodies in Australians who volunteered to get the experimental injection.
Participants who received two doses of the vaccine three weeks apart had neutralising antibody levels roughly four times higher than a group of 32 patients who had recovered from COVID-19.
“We are extremely excited,” Novavax research chief Gregory Glenn said.
“At this point, it looks extremely promising … We have a technology that is extremely good at inducing functional immunity….
-
General23 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
General12 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why
-
General23 hours agoVictims of crypto ATM scams lose $2.5 million as police warn older Tasmanians are targets
-
Noosa News4 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs